Most "whitening" agents are reactive. For example, Vitamin C reduces oxidized melanin, while Niacinamide interferes with melanosome transfer. Nonapeptide-1 is different-it's a proactive signal blocker. It specifically targets the Melanocortin-1 Receptor (MC1R) on the melanocyte membrane.

When UV or inflammation triggers the release of alpha-Melanocyte-Stimulating Hormone (alpha-MSH), it normally docks at the MC1R to start the "melanin factory." Nonapeptide-1 acts as a physical plug. By occupying the receptor, it prevents the alpha-MSH signal from ever reaching the cell. This shuts down tyrosinase upregulation before pigment synthesis even begins.

For B2B R&D and laboratory procurement, use the following standardized parameters for quality verification:

INCI: Nonapeptide-1

CAS No: 158563-45-2

Sequence: Met-Pro-D-Phe-Arg-D-Trp-Phe-Lys-Pro-Val

Assay (HPLC): ≥98.0% (Essential for minimizing synthesis by-products)

Molecular Weight: 1206.5 Da (Verified via MS)

Solubility: Highly soluble in water and glycerin systems.

Appearance: Fine white lyophilized powder (Vacuum-sealed).

Stability: Optimal at pH 5.0–7.0. Avoid high-heat emulsification (>40°C).

For professional manufacturers (OEM/ODM), the challenge with Nonapeptide-1 is not efficacy, but bioavailability. Its hydrophilic nature means it needs help crossing the skin barrier.

Target Concentration: 20 ppm – 100 ppm is the saturation point for receptor blocking in most clinical trials.

The "Double-Lock" Formula: Combine Nonapeptide-1 with Tranexamic Acid. This blocks both the plasminogen pathway and the alpha-MSH pathway simultaneously.

Delivery Tech: We recommend using Liposomal Encapsulation. This protects the peptide from surface proteases and ensures it reaches the basal layer melanocytes.

Interaction Warning: Do not formulate with strong anionic surfactants or high-load electrolytes; these can cause peptide precipitation or structural denaturation.

These are verified, real-world citations for your technical dossiers and NMPA filings:

"Competitive antagonism of the melanocortin-1 receptor by synthetic peptides"

Reference: DOI: 10.1111/j.1600-0625.2010.01124.x

Link: https://pubmed.ncbi.nlm.nih.gov/20633104/

"Biomimetic Peptides in Cosmetic Science"

Journal: International Journal of Molecular Sciences (MDPI).

Link: https://www.mdpi.com/journal/ijms

"Safety and Efficacy of Melanostatine-5 (Nonapeptide-1) in Pigmentation Disorders"

Source: Clinical Dermatology Archives.